(Q37684587)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20118214%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

review article

1 reference

title

Proposal for dosage adjustment and timing of chemotherapy in hemodialyzed patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20118214%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

0 references

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20118214%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Vincent Launay-Vacher

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20118214%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

author name string

J Thariat

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20118214%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

H Boulanger

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20118214%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

G Deray

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20118214%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

publication date

29 January 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20118214%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20118214%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

volume

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20118214%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20118214%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

page(s)

1395-1403

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20118214%20AND%20SRC:MED&resulttype=core&format=json

Effect of different hemodialysis regimens on genomic damage in end-stage renal failure

17 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP598

Increased incidence of malignancy during chronic renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP598

Increased incidence of neoplasia in chronic renal failure (20-year experience).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP598

Cancer incidence before and after kidney transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP598

Drug dosage in patients during continuous renal replacement therapy. Pharmacokinetic and therapeutic considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP598

FHD: an index to evaluate drug elimination by hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP598

International Society of Geriatric Oncology (SIOG) recommendations for the adjustment of dosing in elderly cancer patients with renal insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP598

5-fluorouracil pharmacokinetics: causes for variability and strategies for modulation in cancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP598

Pharmacodynamic study of the Saltz regimen for metastatic colorectal cancer in a hemodialyzed patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP598

Noninvasive measurements of capecitabine metabolism in bladder tumors overexpressing thymidine phosphorylase by fluorine-19 magnetic resonance spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP598

Capecitabine: in advanced gastric or oesophagogastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP598

Effect of renal impairment on the pharmacokinetics and tolerability of capecitabine (Xeloda) in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP598

Carboplatin dosage: prospective evaluation of a simple formula based on renal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP598

Systemic anticancer therapy in gynecological cancer patients with renal dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP598

Cisplatin (cis-diamminedichloroplatinum II)

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP598

Feasibility of combination chemotherapy with cisplatin and etoposide for haemodialysis patients with lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP598

Clinical pharmacokinetics of cyclophosphamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP598

Cyclophosphamide pharmacokinetics and dose requirements in patients with renal insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP598

Pharmacokinetic analysis of docetaxel during haemodialysis in a patient with locally advanced non-small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP598

Pharmacokinetic analysis of combination chemotherapy with carboplatin and etoposide in small-cell lung cancer patients undergoing hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP598

A phase I clinical, plasma, and cellular pharmacology study of gemcitabine

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP598

Measurement of plasma concentration of gemcitabine and its metabolite dFdU in hemodialysis patients with advanced urothelial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP598

The clinical pharmacology of methotrexate.new applications of an old drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP598

Neutropenia associated with the use of low-dose methotrexate in a peritoneal dialysis patient.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP598

Effective clearance of methotrexate using high-flux hemodialysis membranes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP598

Effective removal of methotrexate by high-flux hemodialysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP598

Dose-escalating and pharmacological study of oxaliplatin in adult cancer patients with impaired renal function: a National Cancer Institute Organ Dysfunction Working Group Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP598

Hepatic arterial infusion of oxaliplatin for a patient with hepatic metastases from colon cancer undergoing hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP598

High dose single-agent paclitaxel in a hemodialysis patient with advanced ovarian cancer: a case report with pharmacokinetic analysis and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP598

Paclitaxel and carboplatin combination chemotherapy in a hemodialysis patient with advanced ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP598

Chemotherapy-associated renal dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP598